Response to letter regarding article, ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice

Circulation

Volumn 120, Issue 15, 2009, Pages

  Pokreisz, Peter ^a   Vandenwijngaert, Sara ^a   Marsboom, Glenn ^b   Gheysens, Olivier ^b   Vermeersch, Pieter ^b   Liu, Xiaoshun ^b   Gillijns, Hilde ^b   Pellens, Marijke ^b   Schoonjans, Luc ^b   Janssens, Stefan ^b   Vanhaecke, Johan ^b   Van Den Bergh, An ^a   Herijgers, Paul ^a   Bito, Virginie ^a   Lenaerts, Ilse ^a   Biesmans, Liesbeth ^b   Sipido, Karin ^a   Van Lommel, Alfons ^a   Verbeken, Erik ^a   Busch, Cornelius ^a   Buys, Emmanuel ^a   Bloch, Kenneth D ^a   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; PHOSPHODIESTERASE V; SILDENAFIL; SODIUM PROTON EXCHANGE PROTEIN 1; VARDENAFIL;

CORONARY ARTERY LIGATION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE; HEART VENTRICLE REMODELING; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; REPERFUSION INJURY;

EID: 70350131750     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.872986     Document Type: Letter

References (7)

1. Perez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, Chiappe de Cingolani G, Yang XP, Cingolani HE. Phosphodiesterase 5A inhibition induces Na+/H+ exchanger blockade and protection against myocardial infarction. Hypertension. 2007;49: 1095-1103.
2. Cingolani HE, Ennis IL. Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy. Circulation. 2007;115:1090-1100.
3. Schroder F, Klein G, Fiedler B, Bastein M, Schnasse N, Hillmer A, Ames S, Gambaryan S, Drexler H, Walter U, Lohmann SM, Wollert KC. Single L-type Ca(2 + ) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res. 2003;60:268-277.
4. Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD. cGMP signalling in pre-and post-conditioning: the role of mitochondria. Cardiovasc Res. 2008;77:344-352.
5. Das A, Smolenski A, Lohmann SM, Kukreja RC. Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ische-mia/ reoxygenation in adult cardiomyocyte. J Biol Chem. 2006;281: 38644-38652.
6. Salloum FN, Ockaili RA, Wittkamp M, Marwaha VR, Kukreja RC. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. J Mol Cell Cardiol. 2006;40: 405-411.
7. Tsai EJ, Kass DA. Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther. 2009;122:216-238.